Type 2 diabetes: Combo of semaglutide and cagrilintide reduces blood sugar and leads to weight loss Medha Baranwal1 July 2023 11:00 AM ISTUSA: Co-administration of once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg (CagriSema) improves glycemic control and leads to...
Higher dosage of oral semaglutide useful for chronic weight management and glycemic control Aditi30 Jun 2023 8:15 AM ISTNew indications could be on the horizon for oral semaglutide based on data from OASIS-1 and PIONEER PLUS trials. Presented at the 83rd Scientific...
Medical Bulletin 28/June/2023 Isra Zaman28 Jun 2023 3:05 PM ISTHere are the top medical news for the day: A novel generic treatment for various forms of cancerResearchers led by Katsunori Tanaka at the RIKEN...
High doses of oral semaglutide improve blood sugar control and promote weight loss Isra Zaman28 Jun 2023 9:15 AM ISTDiabetes is a progressive disease that affects one's ability to control blood sugar levels. For many patients, the condition becomes more severe over...
Novo Nordisk sues medical spas, wellness clinics in US over counterfeit drugs Ruchika Sharma23 Jun 2023 10:00 AM ISTNovo Nordisk asked the courts for orders blocking the sales of the unauthorized drugs and an unspecified amount of money damages.
Diabetes medication semaglutide reduces alcohol drinking by half Dr. Kamal Kant Kohli9 Jun 2023 11:30 AM ISTSweden: In a new study, alcohol-dependent rats treated with semaglutide showed significantly reduced alcohol consumption and even reduced drinking of...
Semaglutide improves cardiovascular health in users in addition to causing weight loss: Study Medha Baranwal31 May 2023 11:15 AM ISTUSA: Semaglutide use in obese/overweight patients may decrease the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in addition to...
Semaglutide use in overweight/obese patients tied to reduced CVD risk Dr. Kamal Kant Kohli24 May 2023 10:00 AM ISTUSA: Semaglutide use in overweight/obese patients is associated with a decrease in the 10-year risk of atherosclerotic cardiovascular disease (ASCVD),...
Semaglutide use tied to significant weight loss in multicentre, one-year real-world study Dr. Kamal Kant Kohli23 May 2023 11:00 AM ISTUSA: Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is shown to be effective in a multicentre, 1-year-long real-world study...
Semaglutide use in adolescents can reduce liver enzymes indicative of liver damage: STEP TEENS trial analysis Dr. Kamal Kant Kohli20 May 2023 11:30 AM ISTAustria: Semaglutide use may significantly reduce the liver enzymes indicative of liver damage, a new substudy of the STEP TEENS trial has...
Medical Bulletin 19/May/2023 Isra Zaman19 May 2023 4:30 PM ISTHere are the top medical news for the day:Study finds marijuana users to be thrice more likely to develop peripheral artery diseaseMarijuana use has...
Single one-hour endoscopic procedure could potentially control type 2 diabetes Dr. Kamal Kant Kohli2 May 2023 10:45 AM ISTResearchers have developed a procedure that uses controlled electrical pulses to induce changes to the lining of the first part of the small intestine...
